Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases Publisher Pubmed



Ghiasvand F1 ; Ghadimi M2 ; Sadr S3 ; Jafari F3, 4 ; Manafi N4 ; Ahmadinejad Z1 ; Tirgar S5 ; Seyedalinaghi S6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  3. 3. Mazandaran University of Medical Sci-ences, School of Medicine, Sari, Iran
  4. 4. Iran University of Medical Sciences, School of Medicine, Tehran, Iran
  5. 5. Depart-ment of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran

Source: Infectious Disorders - Drug Targets Published:2021


Abstract

Background: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. Case Presentation: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful out-come. Conclusion: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is need-ed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19. © 2021 Bentham Science Publishers.